Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2012
06/06/2012CN102485260A Ointment composed of radix astragali and garden burnet
06/06/2012CN102485254A Traditional Chinese medicine composition with characteristics of clearing heat and detoxifying, cooling blood and freeing strangury as well as its preparation method
06/06/2012CN102485238A Ligusticum chuanxiong Hort-radix angelicae dahuricae analgesia preparation
06/06/2012CN102485220A Nimesulide monolayer osmotic pump controlled release tablet
06/06/2012CN102120022B Medicament for treating pain and fever caused by cancer
06/06/2012CN102018806B Gardenin channel-relaxing powder and preparation method thereof
06/06/2012CN101966237B Medicament for treating paralysis and preparation method thereof
06/06/2012CN101940609B Medicinal liquor for treating dysmenorrhea
06/06/2012CN101757469B Medicament for treating rheumatoid arthritis and preparation method thereof
06/06/2012CN101590109B Compound preparation for treating back pain caused by senile osteoporosis and preparation method thereof
06/06/2012CN101553225B The uses of the carboxy-amido-triazole compounds
06/06/2012CN101440116B Glycyrrhizin, preparation and use thereof
06/06/2012CN101416964B Use of sophocarpine in preparing medicine for treating diseases induced by coxsackie B virus
06/06/2012CN101060863B Modulation of neuroglia-derived BDNF in the treatment and prevention of pain
06/05/2012US8193249 Triptolide analogs for the treatment of autoimmune and inflammatory disorders
06/05/2012US8193247 Phenolic hydrazone macrophage migration inhibitory factor inhibitors
06/05/2012US8193231 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193230 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193229 Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
06/05/2012US8193209 Analgesic combination of oxycodone and meloxicam
06/05/2012US8193195 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
06/05/2012US8193178 Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
06/05/2012US8193164 Organic compounds
06/05/2012US8192732 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
06/05/2012CA2596013C Benzoimidazole derivatives and pharmaceutical composition comprising the same
06/05/2012CA2571019C 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
06/05/2012CA2557275C Bicyclo derivative
06/05/2012CA2507530C Rapamycin and il-10 for the treatment of immune diseases
06/05/2012CA2482041C 4-chromanone derivatives for treating cellular proliferative diseases and disorders
06/05/2012CA2435419C Halogenated composition, method for preparing same and uses thereof
06/05/2012CA2406278C Inhibitors of human phosphatidyl-inositol 3-kinase delta
06/05/2012CA2368670C Modulation of vascular permeability by means of tie2 receptor activators
06/05/2012CA2324226C Inhibitors of caspases
05/2012
05/31/2012WO2012071414A2 Quinoxaline compounds and uses thereof
05/31/2012WO2012071186A1 Modulators of s1p receptors
05/31/2012WO2012071184A1 Indole derivatives as modulators of s1p receptors
05/31/2012WO2012070033A1 An implant for the controlled release of pharmaceutically active agents
05/31/2012WO2012070027A1 A drug delivery device
05/31/2012WO2012069525A1 Inhibitors of sp140 and their use in therapy
05/31/2012WO2012069275A1 Glycine derivatives and their use as muscarinic receptor antagonists
05/31/2012WO2012068612A1 Methods of treating eye diseases associated with inflammation and vascular proliferation
05/31/2012WO2012047645A3 Combination treatment for rosacea
05/31/2012WO2012040719A3 Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders
05/31/2012WO2011140132A9 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
05/31/2012US20120136157 Aryl ureas as kinase inhibitors
05/31/2012US20120136066 Glomerulonephritis Treatment
05/31/2012US20120136060 Immediate release and sustained release ibuprofen dosing regimen
05/31/2012US20120136059 Combinations of adapalene and benzoyl peroxide for treating acne lesions
05/31/2012US20120136057 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis
05/31/2012US20120136046 Method of treating age related disorders
05/31/2012US20120136035 4-(1-(3-(hydroxymethyl)-2-methylphenyl)ethyl)-1h-imidazole-2(3h)-thione
05/31/2012US20120136034 Fatty acids as anti-inflammatory agents
05/31/2012US20120136026 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
05/31/2012US20120136022 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
05/31/2012US20120136019 (s)-n-methylnaltrexone
05/31/2012US20120136014 Dihydrofolate reductase inhibitors
05/31/2012US20120136013 Organic compounds
05/31/2012US20120136000 Tri-cyclic pyrazolopyridine kinase inhibitors
05/31/2012US20120135994 Inhibitors of human phosphatidylinositol 3-kinase delta
05/31/2012US20120135993 Cyclic triazo sodium channel blockers
05/31/2012US20120135992 Cyclic triazo sodium channel blockers
05/31/2012US20120135984 Dual-action inhbitors and methods of using same
05/31/2012US20120135975 Substituted Esters as Cannabinoid-1 Receptor Modulators
05/31/2012US20120135959 Metalloprotein inhibitors containing nitrogen based ligands
05/31/2012US20120135957 Compositions containing mixtures of fermentable fibers
05/31/2012US20120135955 External Preparation Containing NSAIDs And Method For Producing The External Preparation
05/31/2012US20120135942 Beta-hairpin peptidomimetics
05/31/2012US20120135941 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
05/31/2012US20120135939 Cyclosporin Analogs
05/31/2012US20120135937 Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
05/31/2012US20120135929 Methods Of Modulating Uric Acid Levels
05/31/2012US20120135916 Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
05/31/2012US20120135912 Polypeptide inhibitors of vla4
05/31/2012US20120135094 Oregano and mint anti-inflammatory compositions and methods
05/31/2012US20120135087 Topical compositions designed to maintain or restore the integrity of the mucous membranes
05/31/2012US20120135044 Instant thickener comprising probiotics for hot or cold foods and beverages to be administered to dysphagic patients
05/31/2012US20120135041 Immunosuppressor based on the blockage of tcr-nck interaction
05/31/2012US20120135036 Bacterial composition and its use
05/31/2012US20120135022 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3
05/31/2012US20120135011 Method for in vivo expansion of T regulatory cells
05/31/2012US20120135009 Cleaved and Phosphorylated CRMP2 as Blood Marker of Inflammatory Diseases of the Central Nervous System
05/31/2012US20120135008 Methods and compositions for targeting polyubiquitin
05/31/2012US20120135005 ANTI-TNF-a ANTIBODIES AND THEIR USES
05/31/2012US20120134997 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
05/31/2012US20120134988 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
05/31/2012US20120134973 Novel use of probiotics
05/31/2012US20120134968 Composition for manufacturing a scaffold for tissue engineering, and a method of making it
05/31/2012US20120134958 Hydroxyethyl starch-containing polypeptide compositions
05/31/2012US20120134935 Use of mometasone furoate for treating airway passage and lung disease
05/31/2012US20120134934 Glycine derivatives and medicinal compositions thereof
05/31/2012US20120134925 Application and Uses of PRG4 and Therapeutic Modulation Thereof
05/31/2012US20120132204 Unit dose dry powder inhaler
05/31/2012DE102010052939A1 Ointment-shaped agent, useful e.g. as pain relieving ointment, comprises a carrier substance and many substances comprising heparin, hydroxyethyl salicylate, diclofenac, and essential oil and/or at least a part of the essential oil
05/31/2012DE102010052847A1 Verfahren zur Herstellung einer PPI-haltigen pharmazeutischen Zubereitung A process for the preparation of a pharmaceutical preparation containing PPI-
05/31/2012CA2820600A1 Glycine derivatives and their use as muscarinic receptor antagonists
05/31/2012CA2815390A1 Methods of treating eye diseases associated with inflammation and vascular proliferation
05/30/2012EP2457906A1 Derivatives of 1,2,4-benzothiadiazine dioxide, their preparation and use as allosteric modulators of the AMPA receptor
05/30/2012EP2457903A1 Cannabinoid receptor ligands
05/30/2012EP2457897A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
05/30/2012EP2457573A1 Methods of use of glycomimetics with replacements for hexoses and N-Acetyl hexosamines
1 ... 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 ... 1272